Clinical Trial Update: Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial investigating inhaled human interferon α1b solution for respiratory syncytial virus infections in children is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Interferon α1b inhalation solution (interferon alpha-1b inhalation solution)

Snippet

Sponsor: Kexing Biopharm Co., Ltd. | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: RECRUITING